Statistics for Design and development of novel irreversible GSK-3β inhibitors to address Alzheimer's disease

Total visits

views
Design and development of novel irreversible GSK-3β inhibitors to address Alzheimer's disease 14

Total visits per month

views
July 2024 2
August 2024 2
September 2024 1
October 2024 1
November 2024 1
December 2024 0
January 2025 0

File Visits

views
hamann_design_2018.pdf 110